Already a subscriber?The new chief executive of Healius has suggested the pathology group’s former management was “defensive” and made excuses about the company’s poor performance, telling staff a strategic review that could involve asset sales would be finished quickly.
Mr Anderson warned staff to prepare for a substantial amount of “noise” as the company, the country’s second-largest pathology group, came. That work is being done by UBS, and could recommend selling some of its divisions including the flagship Lumus Imaging business. “Whilst the sale of imaging would solve the near-term gearing issue, it wouldn’t solve the profitability and structural challenges faced by the division, which will take years to resolve, in our view.”as chief executive. The company’s former chairwoman, Jenny Macdonald, left the board in November after failing to gain the backing of enough investors for her re-election after the company, once known as Primary Health Care, lost $2 billion in value in two years.
Business Business Latest News, Business Business Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: FinancialReview - 🏆 2. / 90 Read more »
Source: FinancialReview - 🏆 2. / 90 Read more »